Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Changes in Visual Function and Thickness of Macula after Photodynamic Therapy for Age-related Macular Degeneration

Purpose: To determine the correlation between the changes in the central retinal sensitivity and the changes in the foveal thickness (FT) after photodynamic therapy (PDT) for age-related macular degeneration (AMD). Methods: Nineteen eyes of 19 patients with choroidal neovasularizations (CNVs) secondary to AMD were studied. The pretreatment values of the central retinal sensitivity determined by Micro Perimeter 1 (MP1; Nidek Technologies), best-corrected visual acuity (BCVA), and optical coherence tomography (OCT)-determined FT were compared to the postoperative values at three and six months after PDT. Results: At six months, the retinal sensitivity within the central 10° was significantly improved (P = 0.02) and the FT was significantly thinner (P = 0.016). The BCVA, however, did not change significantly (P = 0.80). The changes in the retinal sensitivities were significantly correlated with the changes in the decrease in the FT (r =-0.59, P = 0.012 within the central 10°) at six months after PDT. Conclusion: Significant improvements in retinal sensitivities within the central 10° and a decrease in FT were observed even though the BCVA was not significantly improved. The measurement of retinal sensitivity by MP1 may be a better method to assess central visual function than the conventional visual acuity after PDT.

[1]  A. Penman,et al.  Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration with Verteporfin , 2020, 50 Studies Every Ophthalmologist Should Know.

[2]  M. Mandai,et al.  Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.

[3]  S. Yamamoto,et al.  Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema , 2006, Eye.

[4]  S. Harding,et al.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study , 2005, British Journal of Ophthalmology.

[5]  U. Schmidt-Erfurth,et al.  Effects of verteporfin therapy on central visual field function. , 2004, Ophthalmology.

[6]  S. Binder,et al.  Reading Ability and Central Visual Field after Photodynamic Therapy , 2004, Ophthalmologica.

[7]  C. Frennesson,et al.  Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope , 2003, Vision Research.

[8]  D. Grosof,et al.  Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. , 1996, Ophthalmology.

[9]  K. Rohrschneider,et al.  Microperimetry--comparison between the micro perimeter 1 and scanning laser ophthalmoscope--fundus perimetry. , 2005, American journal of ophthalmology.

[10]  Michael Stur,et al.  Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. , 2003, Ophthalmology.

[11]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.